Recombinant Human vif Protein，His

Vif (Virion Infectivity Factor) is a key protein produced by the Human Immunodeficiency Virus (HIV) that plays a crucial role in counteracting the antiviral activity of host cellular factors, specifically a class of proteins known as APOBECs (Apolipoprotein B mRNA Editing Enzyme Catalytic Polypeptides). APOBECs can edit the viral DNA during reverse transcription, leading to the incorporation of mutations that severely impair viral replication. However, Vif helps HIV evade this restriction by targeting APOBECs for degradation through the ubiquitin-proteasome pathway, thereby preventing their antiviral effects. The study of Vif and its interactions with host factors is essential for understanding HIV pathogenesis and the molecular mechanisms underlying viral evasion strategies. Research into Vif-recombinant proteins is pivotal for developing novel therapeutic strategies, including potential inhibitors that can restore the antiviral activity of APOBECs or otherwise impede HIV replication. Furthermore, Vif's unique structure and functional attributes make it an attractive target for vaccine design, as understanding its role could lead to innovations in immune responses against HIV. In this context, the recombinant production of Vif has become an important area of study, providing critical insights into its biochemical properties and facilitating the exploration of Vif-targeted interventions in HIV treatment.